Virbac is offering a free Rapid Romanowsky stain kit and Coplin jars to practices buying easOtic and Epi-Otic in a new promotion which runs until the end of October.
easOtic is Virbac's treatment for otitis externa. It features a 1ml airless pump for precise measurement and an award-winning bottle design to aid compliance by ensuring easy and accurate application.
Epi-Otic is Virbac's antibacterial and antifungal ear cleaner for use in routine cleaning. It is pH neutral and contains sodium docusate, which dries the ear canal after application.
Practices making a qualifying purchase of both products will receive the Stain Kit, comprising the three staining solutions and three Coplin jars, free of charge.
For further information, contact your Virbac Territory Manager.
The BSAVA has launched the BSAVA Manual of Canine and Feline Radiography and Radiology with a new introductory text aimed at veterinary students, nurses and new graduates.
The Association says confident radiographic interpretation presents a considerable challenge and the BSAVA Manual of Canine and Feline Radiography and Radiology provides a comprehensive review of the approach to radiological interpretation, the range of variants and the key fundamental principles and their application to common diseases.
The manual features high quality radiographic reproductions demonstrating normal anatomy and key aspects of interpretation, as well as illustrations showing patient positioning and the practical approach that is the hallmark of the BSAVA manuals.
The book contains the following contents:
An extra feature is the CD, which contains all the radiographic images from the manual, so that readers can view the many images at an enlarged size.
The manual is available from October and can be ordered from www.bsava.com.
The RCVS Disciplinary Committee has suspended a London-based veterinary surgeon from the Register for six months, having found that her falsification of clinical records amounted to serious professional misconduct.
At the two-day hearing, Dr Nicola Ersilova was charged with, and admitted to, three separate incidences of false and dishonest clinical record keeping following her treatment of a collapsed cat, whilst working at Vets Now in Thamesmead, London.
The Committee heard how Dr Ersilova had suspected that Lafite the cat, belonging to Mr Yingzhan Xiao, had been poisoned, so administered fluids and treated her with Lidocaine. A lay colleague, who was assisting with the treatment, subsequently observed Dr Ersilova standing staring at the cat, which had stopped breathing, then leaving the room to go and speak to Mr Xiao. The lay colleague's evidence confirmed to the Committee that Lafite's heart was still beating at this point, and that Dr Ersilova was then heard telling Mr Xiao that Lafite had died while being treated. The lay colleague later discovered that Dr Ersilova had listed calcium gluconate on Mr Xiao's bill and not Lidocaine and, when she questioned the entry, Dr Ersilova told her she was worried about getting into trouble if she had listed Lidocaine.
Whilst reporting these irregularities to the senior veterinary surgeon at Vets Now, the lay colleague noticed that Dr Ersilova had also written "CPR unsuccessful" in the notes, although she was certain CPR (cardiopulmonary resuscitation) had not been attempted.
During a subsequent Vets Now investigation, Dr Ersilova admitted adding this false information concerning Lidocaine, calcium gluconate and CPR, saying during interview that she was aware it was serious professional misconduct and that she was prepared to take the consequences. Vets Now reported the matter to the RCVS.
The Committee considered that all evidence before it fully supported the charges against Dr Ersilova, that her conduct was clearly dishonest, and that her actions were inexcusable, especially for someone as experienced as she was. It stated that a veterinary surgeon's duty to make only truthful and accurate records was so manifest and well known to veterinary surgeons that there could be no real excuse to make such false, misleading and dishonest entries.
The Committee highlighted the comment by Dr Ersilova that she knew she had done something wrong but did not expect her colleague to report her, as providing no explanation, or excuse, for doing something which she knew to be wrong.
A number of submissions were made to the Committee in mitigation, including that Dr Ersilova had admitted her dishonesty to both her employers and the Committee; had an otherwise unblemished record over 22 years of practice; had received no immediate financial gain by her actions; and, did not cause any animal suffering.
Accepting these submissions, the Committee nevertheless felt it needed to balance them against other factors. Dr Ersilova's decision to falsify the records was premeditated and had not been taken without an opportunity for full reflection. There were numerous entries in the RCVS Code of Professional Conduct that highlighted the importance of professional integrity and accuracy, and, given the importance which the Code attached to the duty of veterinary surgeons to be truthful and honest in all their dealings with their clients, the Committee found Dr Ersilova's conduct to be "most reprehensible".
Speaking on behalf of the Disciplinary Committee, its Vice-Chairman, Professor Sheila Crispin, said: "It is of great importance that the public should be able to retain confidence in the honesty and integrity of members of the profession. Both the public and other members of the profession must be entitled to rely on the truthfulness of what a veterinary surgeon has written in the clinical records of any animal [they have] treated.
"It is [our] decision that the sanction of suspension adequately reflects the seriousness of the [Dr Ersilova's] conduct. The sanction imposed is ... the most appropriate to inform the profession how seriously such dishonest conduct will be taken, because such conduct clearly brings the profession into disrepute and ... cannot and will not be tolerated."
The Committee then concluded that the least period of suspension that could be justified was one of six months.
Virbac has announced that Ovarid is back in stock following the resolution of a manufacturing problem.
The megestrol acetate tablets are indicated for the postponement or prevention of oestrus and the treatment of hypersexuality in male dogs. In cats they are recommended for the prevention or postponement of oestrus and the treatment of miliary dermatitis and eosinophilic granulomata.
Virbac says that because the product is relied on by the owners of many cats suffering from miliary eczema, it has worked to ensure that their welfare is not compromised by recalling unused Ovarid stock from practices to ensure that it could still be provided to those contacting them with emergency cases since the outage began in February.
Senior Product Manager Chris Geddes MRCVS said: "I'd like to express my thanks to practices for bearing with us and particularly to those which returned unused product. This meant that we were able to supply emergency supplies for the treatment of miliary eczema to every practice that asked for it. We also managed to help out some zoos which needed supplies for frisky sea lions and lions."
Ovarid is available in 20mg and 5mg tablets.
CVS has launched a buying group open to independently-owned practices to benefit from the knowledge, experience and strength of the 250 practices which form CVS.
The new buying group is called MiVetClub. It offers a range of services, including:
Sara Armitage, Director of Product and Buying at CVS, said: "There are many thriving independent practices out there which have the potential to be even more successful if they just had the time and expertise to negotiate better deals and had access to the business resources and support to help them run their practices more efficiently and cost-effectively.
"That's where MiVetClub can help. CVS' stature in the veterinary sector means that we can negotiate the very best discounts and rebates for the group's members. But MiVetClub isn't just about saving money. It's also about helping independent practices raise clinical standards and run better businesses. MiVetClub experts are constantly on-hand to advise members on all aspects of running their practice, freeing up their time to concentrate on what they do best, caring for their patients."
For more information, visit: http://www.mivetclub.com/
MSD Animal Health has announced a new claim for Bovilis BVD and Bovilis IBR Marker Live vaccines which means they can be mixed and administered in a single syringe.
MSD says the new mixing claim will offer significant advantages in herd health planning when controlling two of the more important infectious diseases in cattle.
Bovine Viral Diarrhoea (BVD) and Infectious Bovine Rhinotracheitis (IBR) remain major threats to cattle health and productivity. Vaccinations are commonly given at housing and/or turnout, which are both busy times for veterinary surgeons and on the farm in the herd health planning calendar.
The mixed vaccines are suitable only for booster vaccinations of animals from 15 months of age previously vaccinated separately with Bovilis IBR Marker Live and Bovilis BVD. The mixed vaccine needs to be used within three hours.
MSD says the mixing procedure is clear and easy, but there is an instructional video here: http://www.msd-animal-health.co.uk/Mixing_bovilis_BVD_Bovilis_IBR-Marker_Live.aspx
CVS has announced the acquisition of four further veterinary practices bringing the total number of practices it owns across the UK to 92 operating from 253 sites.
The latest practices to join CVS are: Crescent Veterinary Clinic Ltd, Melton Mowbray; Miller & Swann Veterinary Surgery, Elgin; West Mount Vets, Halifax and Anchorage Veterinary Hospital, Acle.
CVS now employs more than 2,300 staff at its veterinary practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, two pet crematoriums and six veterinary laboratories.
Novartis Animal Health has launched Helping Hearts, a competition in which veterinary surgeons have the chance to brush up on their cardiology whilst at the same time triggering a donation to Hounds for Heroes and entering the running to win one of 10 Red Letter Day experiences.
To enter the competition, visit www.notjustoneheart.com.
Each entry triggers a donation of £1 to Hounds for Heroes, a charity which provides specially trained assistance dogs to injured and disabled men and women of both the UK Armed Forces and Civilian Emergency Services.
Hounds for Heroes was set up by Allen Parton, who was himself injured in service. Allen freely admits that he owes his life to Endal - a Labrador that developed skills beyond his initial basic training and who proved so inspiring to everyone who met him and that he was awarded the accolade 'Dog of the Millennium'. With three squadrons of puppies currently in basic training, there are hopefully a few more canine heroes like Endal waiting in the wings.
Senior Category Manager Cardiology/Nephrology Brock Abreu said: "Here at Novartis Animal Health, we are absolutely thrilled to be supporting such a life-changing and life-enhancing cause. I know this is a charity that many vets feel they can relate to and we are encouraging as many of them as possible to take part. I'd be delighted if we were inundated with entries and could make an impressive donation to Hounds for Heroes on behalf of vets across the country."
The competition is open till 31st December 2013.
Animalcare has announced the launch of a new epilepsy monitoring programme to support users of its Phenoleptil (phenobarbital) tablets.
As part of the programme, veterinary surgeons can have patients' phenobarbital plasma levels analysed by Carmichael Torrance Diagnostic Service (CTDS). CTDS Veterinary Director Nick Carmichael (RCVS Recognised Specialist in Veterinary Clinical Pathology) and his team will also be available both to interpret results and discuss all aspects of therapeutic monitoring at no extra cost.
In addition, veterinary surgeons can opt for additional chemistry, including bile acids to assess hepatic function plus haematology. All Phenoleptil users are eligible for 50% discount off these services.
Animalcare has also expanded the Phenoleptil range and launched new strength tablets of 25mg and 100mg. Presented as new "snap- tabs" with a four-way score for more accurate dosing, whatever the weight of the dog, this enables fine adjustments to be made thereafter, reducing the risk of sub-optimal dosing.
The 100 tablet packs are designed for quick and easy dispensing with flavoured tablets to aid compliance. The 12.5mg and 25mg strengths are the only phenobarbital tablets licensed for dogs under 12kg and make it possible to treat dogs as low as 2.5kg (assuming a 2.5mg/kg bid starting dose) in weight. The 100mg tablets are useful to treat larger dogs.
For more information, contact your local Animalcare representative.
Zea Sciences has announced that its natural rodenticide has been certified under the European Biocide Directive Program, known as Annex1/1A BPD 98/8EEC.
The rodenticide is made from powdered corn cob (PCC) which, according to Zea Sciences, causes rats and mice to die of hypovolemic shock within 4-7 days of starting to feed on it.
The company says PCC poses no health risk to human or non target animal species, such as cats, dogs and birds. It is also the first of its type and class to be officially acknowledged as using naturally biodegradable and environmentally friendly material.
PCC is available from a number of retail and trade outlets, under various different brand names. However, the company said that if there was sufficient interest by vets in stocking the pet-friendly product, it would look at making it available through veterinary wholesalers.
Martin Holland, Managing Director of Zea Sciences said: ''I hope the profession will help spread the word about PCC-based rodent control - it might mean you have to reach for the vitamin K a little less often."
Zoetis has announced that Suvaxyn MH-One, its vaccine against Mycoplasma hyopneumoniae in pigs, has a revised licence allowing it to be administered from seven days of age with a two-week onset of immunity.
The company says this means that piglets can be protected by three weeks of age when they are commonly already infected with M. hyo. Duration of immunity extends well beyond the average UK pig slaughter age of 176 days.
Nigel Lodge, National Veterinary Manager for Zoetis in the UK said: "This is a significant step forward, recognising the full efficacy of the Suvaxyn MH-One vaccine against enzootic pneumonia. Trials have confirmed that use of Suvaxyn MH-One at seven days reduces lung lesions - even in the presence of maternally derived antibodies.
"The vaccine, which adds to our large and growing pig vaccine and product portfolio, also benefits from using adjuvants carbopol and squalane."
According to the company, the performance gains from early protection are shown in a field trial with 240 pigs injected at one week of age which showed significantly higher average daily weight gain, providing nearly 5 kg extra weight over the study period to 166 days.
The RCVS has clarified its role concerning new UK veterinary schools, saying that it has no mandate to control student or graduate numbers.
Responding to calls from the profession that it should comment on the desirability of any change in the number of schools or graduates, the College has confirmed that whilst it is committed to setting, upholding and advancing the standards that any new UK veterinary degrees would need to meet in order to be approved by the Privy Council, it has no role in capping student numbers.
The College also points out that the free market and mobility of workers in the EU makes any control at the level of a sovereign state effectively meaningless with respect to workforce management. However, the College says it is committed to ensuring that standards are maintained, and to continue working with bodies such as the European Association of Establishments for Veterinary Education, which evaluates veterinary degrees across Europe.
The College also seeks to support healthy debate through providing information on the state of the profession - an example of which is the survey that it recently commissioned from the Institute for Employment Studies on job availability for veterinary graduates over the last five years.
The headline results from that survey were released in the summer, and showed that increasing graduate numbers over the last five years have so far appeared to have had little impact on veterinary job prospects, with 94% of graduate respondents seeking a role in clinical practice obtaining work within six months of starting to look.
The full RCVS Survey of Recent Graduates report is now available, and also shows that, of the 43% of veterinary surgeons who graduated in the last five years who responded:
The answers were analysed by year of graduation, veterinary school, age and gender, and the full report is available online at www.rcvs.org.uk/publications.
Rachel Wells, an RVN and Pet Health Counsellor (PHC) from Pype Hayes Veterinary Centre in Birmingham, has won Royal Canin's annual 'Pet Health Counsellor of the Year' Awards 2013.
The ceremony, which took place earlier this month at the Forest of Arden Marriot Hotel in Birmingham, saw Rachel beat 25 other finalists to claim the Gold Award. Royal Canin presented Rachel with £1,500 worth of high-street vouchers at the annual ceremony, which celebrates veterinary professionals for promoting preventative health care and running pet health clinics in practice.
The Erdington-based PHC, was chosen by animal behaviour expert Sarah Heath for her work in weekly puppy parties, general 'nutrition mission' clinics and firework and weight clinics. She was also recognised for her one-off work in running an 'Embarrassing Pet Bodies' workshop in the summer, similar to the 'Embarrassing Bodies' Channel 4 TV documentary.
Royal Canin's Veterinary Sales and Marketing Director, Andrew Doyle, said: "It's a privilege to be able to present Rachel with the award. She has demonstrated an outstanding contribution to Pype Hayes Veterinary Centre, by running a variety of specialist sessions for owners which have proven very popular and beneficial. The Royal Canin Pet Health Counsellor scheme was set up to encourage Veterinary Nurses to advance their professional development, so it was great to see such a high level of entries this year detailing the PHCs who have set up effective clinics and services in their practice."
Rachel said: "It is an honour to receive Royal Canin's Pet Health Counsellor of the Year award. It's a fantastic opportunity and the scheme they run has given me the chance and confidence to develop specialist clinics at Pype Hayes Veterinary Centre. We have set up many sessions including weight and nutrition clinics to give our clients the specific advice and training for their pets' needs."
BCF Technology has published a new clinical guide to the non-reproductive applications of ultrasound in farm animals.
Kimberly Palgrave BS BVM&S, created the booklet with the aim of helping veterinary surgeons understand the value in using ultrasound for more than reproduction purposes.
BCF says On farm ultrasound uses: Beyond pregnancy diagnosis provides key clinical descriptions and tips, along with normal and abnormal ultrasound images to show how ultrasound can aid in diagnosing various on-farm conditions you may be presented with, such as scanning the teat to detect stenosis, the umbilical area for an abscess, and even the thorax for help to diagnose BRD.
Kimberly said: "This clinical guide was created to help vets get more out of on farm ultrasound than just pregnancy diagnosis. There are a range of other uses for ultrasound on farm and this guide explains how to use your equipment for these applications. As always we are happy to receive feedback on any of our clinical materials."
To find out more or to get your copy of the guide, visit the learning section of the BCF website: www.bcftechnology.com
Elanco has launched the second issue of its dermatology e-newsletter 'Under The Skin', which focuses on fleas and the problem of flea infestations.
Guest edited by Dr Peri Lau-Gillard DerMedVet CertVD DipECVD MRCVS, European Specialist in Veterinary Dermatology, the newsletter reviews the flea life cycle and considers their role as parasite and vector.
Other topics covered include 'seasonal treatment or year round prevention', 'treatment failure - what to consider when the fleas are still alive', 'tips and tricks - flea combing and faecal examination for fleas' and information about spinosad, the active ingredient in Comfortis.
There is also a chance to watch the recent 'real world flea control' webinar presented by flea expert, Dr Mike Dryden, together with a film demonstrating the effect of treatment with a Comfortis tablet on adult fleas.
Issue three of Under The Skin will take a closer look at the flea's role in allergic skin disease and how to manage these sometimes complex and frustrating cases.
To register to receive Elanco's Under The Skin e-newsletter, visit www.thewebinarvet.com/elanco.
Alstoe, maker of a range of veterinary products including Easeflex, Vetergesic, Dolagis and Nelio, has announced that it has changed its name to Sogeval UK Ltd following its acquisition by Sogeval, the French veterinary drug company, earlier this year.
The company says customers will not notice any change to their dealings with the company, because Sogeval UK Ltd will trade from the same premises near York and with the same staff members.
Niall McFerran, Sogeval Country Manager, UK and ROI said: "The change of name to Sogeval UK Ltd aligns the business to one of the world's fastest growing Animal Health companies. Through Sogeval's research and development programmes, we look forward to exciting improvements in the future."
For any questions relating to the change, practices are invited to contact Niall McFerran on 01347 878606.
The British Veterinary Association has appointed David Calpin as its new Chief Executive. David joins the BVA from Defra, where he was a Deputy Director and has held a number of senior management roles. David's policy responsibilities have included climate change, GM crops, sustainable land management, and, most recently, bovine TB. For a period last year David was Acting Director for Animal Health and Welfare in Defra.
David has been in the senior civil service since 2005, and has substantial experience of both staff and financial management. He spent two years working in Brussels representing the UK Government in EU negotiations, and has lived and worked in France, South Africa and Brazil. Prior to joining the civil service, David worked for Barclays Bank.
BVA Chairman Derek Williams said: "David's appointment comes at a very exciting time for the BVA as we respond to the challenges set out by our members in our membership research 'Your BVA, Your Say'. David has a proven track record as a senior manager, extensive experience of managing stakeholder relationships, and an excellent understanding of the political climate in the UK and Europe; all of which will ensure BVA continues to thrive and to represent members effectively."
David Calpin said: "I'm delighted to be joining the BVA. I've worked closely with the BVA in my previous roles and have been hugely impressed. I also know that no organisation can afford to stand still, and that the BVA needs to keep pace with changes in the veterinary profession.
"I'm really looking forward to the challenge of leading the BVA through a period of change to become an even more effective voice for the profession and providing services that members value. I have a lot to learn and I'm keen to get out and about to meet as many people as possible and to hear first-hand what the profession wants from the BVA."
Merial has announced the results of a survey which suggests that whilst diagnosis of gastric ulcers in horses is improving, there is still room for improvement.
The survey of 50 equine vets, which was conducted in May this year, showed that the number of practices owning a scope has more than doubled over the past six years. Half of equine practices now own a scope. Over the same period the average number of monthly scopes has risen from 1.5 to 9.25 and referrals from practices without a scope has risen by 65%.
Merial's Louise Radford MRCVS said: "The survey also showed that symptom recognition among vets prompting the need for an endoscopy has also risen. The vast majority of vets now consider changes in behaviour, loss of appetite and poor performance as potential signs. In addition, 100% of those surveyed would consider an endoscopy when presented with the signs of recurring colic.
"However whilst this is great progress, when diagnosis is compared to the incidence of ulcer, we know that more needs to be done. It is believed that up to 30% of leisure horses have some degree of gastric ulceration, and this increases in sports horses, yet just a fraction of this figure represents those scoped."
Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine at B&W Equine Hospital says he is pleased that more horses are being scoped for gastric ulcers but says that further education is needed: "We've seen a huge leap in the appreciation of the incidence of gastric ulceration in non-racing animals, which long term will better our understanding of the individual clinical relevance of particular lesions, and the benefits of treatment and management change.
"This should improve both performance and horse welfare, as well as increasing client satisfaction. Despite the huge increase in the diagnosis and treatment of equine gastric ulcers it is still believed that many horses go undiagnosed."
The British Veterinary Association is asking members to put themselves forward as candidates in the upcoming elections for BVA Council.
In eight of the 12 regions BVA is seeking regional representatives who are willing to gather and represent the views of their peers as part of the BVA's policy-making process.
Nominations opened on 4 November in Northern Ireland, Wales, North-East, North-West, Yorkshire & Humber, East Midlands, West Midlands, and London and will run for six weeks (until Friday 13 December).
The remaining four regions (Scotland, South-East, South-West, and East of England) will be up for election in 2015 to allow for a level of continuity on BVA Council.
BVA President Robin Hargreaves said: "BVA Council is the overarching policy-making body at BVA and its success depends in large part on the fantastic work of our regional representatives who ensure that every member of our association has the ability to feed in their views and ideas.
"We're looking for people who enjoy getting involved in current issues and who will work hard to put forward the views of their colleagues and to disseminate information out to the wider membership."
Application packs, including an information sheet, role description, and application form, are available to download from the BVA website www.bva.co.uk/council
Candidates in each of the eight regions will be announced shortly after the closing date. The election process will be run by the Electoral Reform Services on behalf of BVA and all members within a region will be eligible to vote. The election will run from Monday 13 January until Friday 21 February. Winning candidates will take up their role at the April Council meeting.
The BVA has responded to the Written Ministerial Statement from the Defra Secretary of State at the end of the licence for badger culling in Somerset.
BVA President Robin Hargreaves said: "The British Veterinary Association (BVA) has supported the pilot culls in England to determine whether badger culling can be delivered humanely, effectively, and safely by controlled shooting.
"We will not prejudge the report of the Independent Expert Panel (IEP), which will consider data from the initial 6-week pilots in Somerset and Gloucestershire, but we are interested to note the Secretary of State's announcement that current indications suggest that the pilot has been safe and humane.
"Today our Veterinary Policy Group has discussed the issues surrounding the extensions to the licences. We agree with the Chief Veterinary Officer's advice that extensions in order to remove a greater number of badgers and get closer to achieving the 70% rate of the Randomised Badger Culling Trials (RBCTs) are justified to improve the bovine TB disease situation and mitigate the potential impact of badger perturbation.
"Following questions raised by our members we have been assured by Defra that monitoring of the culling will continue to ensure it is being carried out in accordance with the humaneness and safety stipulations in the licences. Although it is important to note that this data will not form part of the information being considered by the IEP.
"We await the report of the IEP and will engage members in considering what impact it will have on the overall bovine TB eradication strategy for England."
According to reports in the Daily Telegraph and the Daily Mail yesterday, there's a new craze on the Internet called dog shaming, where owners post a photograph of a guilty-looking pet online, together with a witty caption.
A quick Google search reveals a number of websites dedicated to the practice, including: www.dogshaming.com, www.dog-shame.com, petshaming.net and shameyourpet.com.
However, according to research carried out by Bayer to promote Drontal, 40% of owners mistake the behavioural signs displayed in some of the photographs for guilt or shame, when in reality the dog is showing signs of fear.
Predictably, a number of organisations have condemned dog shaming. Caroline Kisko, Secretary of the Kennel Club said: "The idea of shaming a dog is daft. Dogs don't like having the mickey taken out of them and can undoubtedly plug into that. So why would you do that to your pet? You wouldn't mock your family or your friends like this, so why your dog?."
Veterinary surgeon and TV presenter Paul Manktelow had a more balanced take on it all. He said: "It is a positive thing that owners love their dogs enough to make light of bad behaviour at times, and can look back and laugh at their mischievous antics. However, it is important to note that dogs may in fact be expressing apprehension and fear, and not have been misbehaving in the first instance, just doing what comes naturally. People should also recognise the subtle behaviourial signs that indicate stress or an underlying health issue."
The Kennel Club has announced that it now recognises the Portuguese Pointer, bringing the total number of recognised pedigree breeds in the UK to 212.
The Portuguese Pointer is only the second new breed to be recognised by the Kennel Club in the last five years.
However, as exotic dog breeds have risen in popularity, the Kennel Club reports that many native breeds have fallen out of favour and have been put on its list of 'vulnerable native breeds'; those with less than 300 annual puppy registrations which could disappear from our streets and parks if their numbers continue to decline.
New statistics released by the Kennel Club have shown that whilst vulnerable native breeds have increased in number this year, certain breeds such as the Sealyham Terrier and Otterhound continue to decline. Recent years have seen the Old English Sheepdog and English Setter enter the 'at watch' list. Furthermore, with just 239 Pembroke Corgi registrations so far this year, it is feared the Queen's favourite breed could also become vulnerable for the first time.
By contrast, exotic breeds such as the French Bulldog and Smooth Coated Chihuahua (originally from Mexico) are increasing in popularity with 4,843 and 2,931 registrations respectively so far this year. Between 2003 and 2012 the breeds have increased by 1,232% and 700% respectively.
When the first ever Kennel Club stud book was produced in 1874, just 43 breeds were listed, including many native breeds that are now considered to be vulnerable, such as the Dandie Dinmont Terrier, Clumber Spaniel, Otterhound and Skye Terrier.
Some native breeds continue to thrive, including the English Springer Spaniel, the Cocker Spaniel, the Staffordshire Bull Terrier, the Bulldog, the Golden Retriever, and the Border Terrier, all top ten breeds. But others in the top ten are from abroad.
Visitors to Discover Dogs, which is taking place at Earls Court on November 9th and 10th will be able to meet more than 200 breeds of dog under one roof, including the vulnerable breeds and the latest pedigree dog breeds in the UK.
The newly added Turkish Kangal Dog will also be coming to the event. This breed was added earlier this year and was the first new breed to join the Kennel Club register in almost five years. The Greater Swiss Mountain Dog, officially recognised from 1 October 2008, was the last dog recognised by the Kennel Club prior to the two new additions for this year. Organiser of the Kennel Club's Discover Dogs event, Vanessa McAlpine, said: "The UK is lucky to have so many wonderful dog breeds, and at our Discover Dogs event people have a unique opportunity to meet more than 200 of them, including those that might never cross your path in day to day life because they are so rare, those that are new to our shores and those that have been working with people in Britain for hundreds of years."
To find out more about Discover Dogs, visit www.discoverdogs.org.uk/.
Vétoquinol has launched Flexadin, a new range of joint support products for cats and dogs with osteoarthritis (OA)
Robert Simpson, Flexadin Product Manager said: "This new range is made up of two products: Flexadin Plus and Flexadin Advanced, both are dietetic complementary feeds which are members of a small group of joint support products which contain Omega-3 fatty acids and Vitamin E. These ingredients are proven to aid the support of the metabolism of joints in the case of OA. Although many different joint support aids are available, not all of them contain these extra ingredients."
Vétoquinol says that in addition to Omega-3 fatty acids and Vitamin E, Flexadin Plus contains the traditional ingredients: glucosamine, chondroitin and devil's claw. Flexadin Advanced contains the novel ingredient, UCII - a type of undenatured type II collagen which has been manufactured using a patented process.
Flexadin Plus comes in two formulations, the first is specifically designed for cats/small dogs and the other is for medium/large dogs. Flexadin Advanced is specifically for dogs.
Robert added: "Flexadin Advanced has a specific property which means that the administration rate is only one chew per day whatever the weight of the dog. This has an important impact on the price per day for medium and large dogs which may require more than one tablet of traditional joint support products. This property also makes Flexadin Advanced a convenient option for owners. In addition to this benefit, UCII is becoming more and more popular due to the results of scientific studies in dogs, horses and even humans.
"We are all very excited about the advances this range can bring to veterinary practices."
Both Flexadin Plus and Advanced are presented as palatable, shaped, soft chews which come in zip-lock packs to keep the soft chews fresh and tasty. Flexadin Plus comes in packs of 90 chews whilst Flexadin Advanced comes in packs of 30 chews.
For further information about Flexadin, contact Vétoquinol on: 01280 825424.
Bimeda has launched Recocam, a 20mg/ml meloxicam preparation licensed for use as a single injection course in cattle, horses and pigs.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "Meloxicam's anti-inflammatory credentials and safety profile is well proven and it remains rightly popular with large animal vets. With our manufacturing expertise it makes sense to add this widely used product to our portfolio. Our aim is to provide a comprehensive range of both established standards and new innovative products for cattle and equine vets, and this is just another step in that process."
Bimeda says Recocam has a broad range of indications including acute respiratory infections, in combination with oral re-hydration in diarrhoea therapy and acute mastitis, for non-infectious locomotor disorders and lameness in pigs and alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders and pain relief associated with equine colic. In cattle Recocam can be given by single subcutaneous or intravenous injection.
A groundbreaking 3d printing service offered by Replica 3DM, a spin off of Salisbury NHS District Hospital, has helped referral veterinary orthopaedist Andy Moores in carrying out surgery on dog that won the 2013 Crufts Friends For Life Award.
Haatchi is an Anatolian shepherd dog whose back left leg and tail were amputated after he was tied to a railway line and hit by a train. As a rescue dog, he was adopted by the family of a young boy called Owen Howkins from Basingstoke. Owen has Schwartz‐Jampel syndrome, which causes his muscles to be permanently tense. The two bonded and became inseparable.
Earlier this year Haatchi developed mobility issues with his remaining hindlimb. He was referred to Anderson Moores Veterinary Specialists, in Hampshire, where a laterally luxating patella was diagnosed. The patella luxation was a result of a complex deformity of the femur and the tibia. Surgery was needed to enable Haatchi to use his leg better.
Replica 3DM, which normally uses its £70,000 printing equipment to make models of human bones and joints, created a 3d model of Haatchi’s hind leg from hip to paw. Normally the company charges around £200 for a human mandible. So, in order to keep costs down, it suggested a scaled down model which would still make Andy's preoperative planning a lot more straightforward and would help identify the correct surgical approach and likely abnormalities which would be encountered. Andy emailed the CT scans to Matt Sherry from Replica 3DM Ltd who converted them into a 3D model of Haatchi’s leg. Production of the model took six hours.
Andy said: "Having access to a scale 3D model of Haatchi's limb prior to surgery not only allowed us to better understand his deformity but it also allowed us to practice the femoral and tibial corrective osteotomies prior to surgery to be sure they would achieve what we intended."
Replica 3DM Ltd is based at Salisbury District Hospital and provides a service producing 3 dimensional products used in various types of surgery e.g. fractured neck of femur, cranioplasty procedures and jaw fractures. The company says that while of course not necessary in all procedures, visualisation of fractures and deformities prior to surgery can help in pre planning of surgery, reducing costs in time and equipment as well as enabling smaller incisions and less soft tissue intervention, so that patient recovery is enhanced.
For more information, visit www.replica3dm.com or ring Matt Sherry at Replica 3dm on 01722 429185.